Dr Ruth Thieroff-Ekerdt to join Eurand
This article was originally published in Scrip
Executive Summary
Eurand (US), a speciality company developing enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, has appointed Dr Ruth Thieroff-Ekerdt to the newly created position of chief medical officer. Dr Thieroff-Ekerdt was previously vice-president of global clinical and medical affairs at Bayer Consumer Care.